These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Symposium on the experimental pharmacology and clinical use of antimetabolites. IX. The pyrimidine and purine antagonists. BURCHENAL JH; ELLISON RR Clin Pharmacol Ther; 1961; 2():523-41. PubMed ID: 13688926 [No Abstract] [Full Text] [Related]
3. The effect of antimetabolites on the growth of Endamoeba histolytica. I. Purine and pyrimidine analogs. JONSSON S; NAKAMURA M Arch Biochem Biophys; 1957 Jan; 66(1):183-9. PubMed ID: 13395538 [No Abstract] [Full Text] [Related]
4. Antagonists of purine and pyrimidine metabolites and of folic acid. TIMMIS GM Adv Cancer Res; 1961; 6():369-401. PubMed ID: 13921293 [No Abstract] [Full Text] [Related]
5. Special microbiological systems. III. The use of lactic acid bacteria for the evaluation of purine and pyrimidine antagonists. HITCHINGS GH Ann N Y Acad Sci; 1958 Dec; 76(3):490-5. PubMed ID: 13627874 [No Abstract] [Full Text] [Related]
6. [Possibility of chemotherapy for neoplasms with pyrimidine & purine antagonists]. PREZIOSI P Riforma Med; 1957 Dec; 71(49):1411-7. PubMed ID: 13528577 [No Abstract] [Full Text] [Related]
8. Inhibitors of de novo purine and pyrimidine synthesis as immunosuppressive drugs. Allison AC; Eugui EM Transplant Proc; 1993 Jun; 25(3 Suppl 2):8-18. PubMed ID: 8516951 [No Abstract] [Full Text] [Related]
9. Potent inhibitors of de novo pyrimidine and purine biosynthesis as chemotherapeutic agents. Christopherson RI; Lyons SD Med Res Rev; 1990; 10(4):505-48. PubMed ID: 2243513 [No Abstract] [Full Text] [Related]
10. The need for additional alkylating agents and antimetabolites. Heidelberger C Cancer Res; 1969 Dec; 29(12):2435-42. PubMed ID: 4905240 [No Abstract] [Full Text] [Related]
11. [Heliomycin decrease in the pool of purine- and pyrimidine-containing compounds in bacterial cells]. Korolev PN; Bulgakova VG; Polin AN; Silaev AB Mikrobiologiia; 1978; 47(2):203-7. PubMed ID: 351337 [TBL] [Abstract][Full Text] [Related]
12. Effects of purine antagonists on the metabolism of other purine antagonists. HENDERSON JF; JUNGA IG Biochem Pharmacol; 1961 Aug; 7():187-94. PubMed ID: 13713259 [No Abstract] [Full Text] [Related]
13. Chemotherapy of solid tumors. Alberto P Aktuelle Probl Chir; 1970; 14():807-34. PubMed ID: 4147168 [No Abstract] [Full Text] [Related]
15. Antagonism studies with several toxic purines and purine nucleosides in mouse tissue cultures. BIESELE JJ; BERGER RE; CLARKE M Cancer Res; 1952 Jul; 12(7):465-70. PubMed ID: 14936016 [No Abstract] [Full Text] [Related]
16. [Influencing the immune status of cancer patients through chemotherapy]. Micksche M Wien Med Wochenschr; 1975 Dec; 125(50-52):729-35. PubMed ID: 779283 [No Abstract] [Full Text] [Related]
17. Data summaries of selected purine antagonists. Cancer Chemother Rep; 1961 Apr; 11():177-237. PubMed ID: 14447663 [No Abstract] [Full Text] [Related]
18. Experimental evaluation of purine antagonists as anticancer agents. SCHABEL FM Cancer Chemother Rep; 1962 Feb; 16():37-42. PubMed ID: 14497875 [No Abstract] [Full Text] [Related]
19. The effects of some purines and purine-analogues on ascidian embryos. WADDINGTON CH; MANCUSO V Exp Cell Res; 1955 Oct; 9(2):369-71. PubMed ID: 13262054 [No Abstract] [Full Text] [Related]